Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia
Our analysis included 133 AML patients (60 females and 73 males, median age 62 years, range 16–85 years), diagnosed between April 1995 and October 2004. The diagnosis of AML was established according ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback